oAlert.pl
WARNING: RECALLED PRODUCT
PL EN

Ulipristal Alvogen

A new case of severe liver injury requiring transplantation and a justified suspicion that the medicine causes serious adverse reactions, altering the benefit–risk balance and creating a real, high probability of risk to patients’ health or life. Potential effects: severe liver damage, life‑threatening complications.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

Ulipristal Alvogen
Risk Level
Critical
Manufacturer
Alvogen Pharma Trading Europe EOOD, Bułgaria
Batch Number
wszystkie serie
Recall Date
13.03.2020
View official statement

Important Information

What You Should Know

Recommendations

Do not use Ulipristal Alvogen 5 mg from any batch; patients currently taking this medicine should promptly contact their doctor to review the therapy and possibly change treatment.

Actions Taken

All batches of the product were suspended from the market nationwide, the decision was granted immediate enforceability, and the marketing authorisation holder was obliged to undertake actions related...

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

FAQ

Frequently Asked Questions

Is this product safe to consume?
No. This product has been recalled due to: A new case of severe liver injury requiring transplantation and a justified suspicion that the medicine causes serious adverse reactions, altering the benefit–risk balance and creating a real, high probability of risk to patients’ health or life. Potential effects: severe liver damage, life‑threatening complications.
What should I do if I already bought this?
Stop using the product immediately. Return it to the store for a full refund. If you consumed it and feel unwell, contact your doctor.
Which batches are affected?
Affected batch numbers: wszystkie serie

Related

Other Recalled Products